Exelixis
EXEL
#1807
Rank
C$16.03 B
Marketcap
C$59.81
Share price
2.86%
Change (1 day)
22.18%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company